New Zealand markets closed

Atrion Corporation (ATRI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
405.29+5.46 (+1.37%)
At close: 04:00PM EDT
405.29 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close399.83
Open406.60
Bid392.90 x 100
Ask413.76 x 100
Day's range401.50 - 419.19
52-week range274.98 - 630.98
Volume38,753
Avg. volume19,129
Market cap713.246M
Beta (5Y monthly)0.61
PE ratio (TTM)36.78
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield8.80 (2.17%)
Ex-dividend date14 Mar 2024
1y target estN/A
  • GlobeNewswire

    Atrion Reports Fourth Quarter And Full Year 2023 Results

    ALLEN, Texas, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2023 and the full year 2023. For the fourth quarter of 2023 compared to the fourth quarter of 2022, revenues were $43.6 million, up $729 thousand, operating income was $6.7 million, down $2.1 million, and net income was $6.4 million, down $1.9 million. Fourth quarter 2023 diluted earnings per share were $3.65 compared to $4.70 for the fourth quar

  • GlobeNewswire

    Atrion Reports Third Quarter 2023 Results

    ALLEN, Texas, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the third quarter ended September 30, 2023. Revenues for the third quarter of 2023 totaled $41.9 million compared to $44.6 million for the same period in 2022. For the quarter ended September 30, 2023, operating income was $4.1 million, down $5.5 million from the comparable 2022 period, and net income was $2.9 million, down $5.9 million from the same period in 2022. Third quarter 202

  • GlobeNewswire

    Atrion Corporation Announces Election of New Director

    ALLEN, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) announced the election today of Jeannette Bankes as a director, effective immediately. Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms. Bankes served in leadership positions across multiple div